Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment

Arthritis Rheum. 1986 Jan;29(1):133-5. doi: 10.1002/art.1780290118.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abscess / drug therapy
  • Breast Diseases / drug therapy
  • Cough / drug therapy
  • Drug Combinations / adverse effects
  • Erythrocytes / metabolism
  • Erythrocytes, Abnormal / pathology*
  • Female
  • Folic Acid / metabolism
  • Folic Acid Antagonists / adverse effects
  • Humans
  • Leucovorin / therapeutic use
  • Megaloblasts / pathology*
  • Methotrexate / adverse effects*
  • Middle Aged
  • Neutrophils / pathology
  • Pancytopenia / chemically induced*
  • Pancytopenia / drug therapy
  • Pancytopenia / pathology
  • Sulfamethoxazole / adverse effects
  • Trimethoprim / adverse effects
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Drug Combinations
  • Folic Acid Antagonists
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Folic Acid
  • Trimethoprim
  • Sulfamethoxazole
  • Leucovorin
  • Methotrexate